Literature DB >> 20937816

The regulatory mechanism of extracellular Hsp90{alpha} on matrix metalloproteinase-2 processing and tumor angiogenesis.

Xiaomin Song1, Xiaofeng Wang, Wei Zhuo, Hubing Shi, Dan Feng, Yi Sun, Yun Liang, Yan Fu, Daifu Zhou, Yongzhang Luo.   

Abstract

Heat shock protein 90α (Hsp90α) is a ubiquitously expressed molecular chaperone that is essential for eukaryotic homeostasis. Hsp90α can also be secreted extracellularly, where it has been shown to be involved in tumor metastasis. Extracellular Hsp90α interacts with and promotes the proteolytic activity of matrix metalloproteinase-2 (MMP-2). However, the regulatory mechanism of Hsp90α on MMP-2 activity is still unknown. Here we show that Hsp90α stabilizes MMP-2 and protects it from degradation in tumor cells. Further investigation reveals that this stabilization effect is isoform-specific, ATP-independent, and mediated by the interaction between the Hsp90α middle domain and the MMP-2 C-terminal hemopexin domain. Moreover, this mechanism also applies to endothelial cells that secrete more Hsp90α in their proliferating status. Furthermore, endothelial cell transmigration, Matrigel plug, and tumor angiogenesis assays demonstrate that extracellular Hsp90α promotes angiogenesis in an MMP-2-dependent manner. In sum, this study provides new insights into the molecular mechanism of how Hsp90α regulates its extracellular client proteins and also reveals for the first time the function of extracellular Hsp90α in promoting tumor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937816      PMCID: PMC3000986          DOI: 10.1074/jbc.M110.181941

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  A critical role for the proteasome activator PA28 in the Hsp90-dependent protein refolding.

Authors:  Y Minami; H Kawasaki; M Minami; N Tanahashi; K Tanaka; I Yahara
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

Review 2.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

3.  Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms.

Authors:  Lisa Wright; Xavier Barril; Brian Dymock; Louisa Sheridan; Allan Surgenor; Mandy Beswick; Martin Drysdale; Adam Collier; Andy Massey; Nick Davies; Alex Fink; Christophe Fromont; Wynne Aherne; Kathy Boxall; Swee Sharp; Paul Workman; Roderick E Hubbard
Journal:  Chem Biol       Date:  2004-06

Review 4.  Heat-shock protein 90, a chaperone for folding and regulation.

Authors:  D Picard
Journal:  Cell Mol Life Sci       Date:  2002-10       Impact factor: 9.261

5.  Structural and functional analysis of the middle segment of hsp90: implications for ATP hydrolysis and client protein and cochaperone interactions.

Authors:  Philippe Meyer; Chrisostomos Prodromou; Bin Hu; Cara Vaughan; S Mark Roe; Barry Panaretou; Peter W Piper; Laurence H Pearl
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

6.  The regulatory mechanism of Hsp90alpha secretion and its function in tumor malignancy.

Authors:  Xiaofeng Wang; Xiaomin Song; Wei Zhuo; Yan Fu; Hubing Shi; Yun Liang; Maomeng Tong; Guodong Chang; Yongzhang Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-24       Impact factor: 11.205

7.  Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness.

Authors:  Brenda K Eustace; Takashi Sakurai; Jean K Stewart; Dean Yimlamai; Christine Unger; Carol Zehetmeier; Blanca Lain; Claudia Torella; Stefan W Henning; Gerald Beste; Bradley T Scroggins; Len Neckers; Leodevico L Ilag; Daniel G Jay
Journal:  Nat Cell Biol       Date:  2004-05-16       Impact factor: 28.824

8.  Heat shock protein 90alpha-dependent translocation of annexin II to the surface of endothelial cells modulates plasmin activity in the diabetic rat aorta.

Authors:  Hetian Lei; Giulio Romeo; Andrius Kazlauskas
Journal:  Circ Res       Date:  2004-03-04       Impact factor: 17.367

9.  Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.

Authors:  Gurmeet Kaur; Dorina Belotti; Angelika M Burger; Kirsten Fisher-Nielson; Patrizia Borsotti; Elena Riccardi; Jagada Thillainathan; Melinda Hollingshead; Edward A Sausville; Raffaella Giavazzi
Journal:  Clin Cancer Res       Date:  2004-07-15       Impact factor: 12.531

10.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

View more
  46 in total

1.  Heat shock protein 90 inhibition by 17-DMAG attenuates abdominal aortic aneurysm formation in mice.

Authors:  Jia Qi; Ping Yang; Bing Yi; Yan Huo; Ming Chen; Jian Zhang; Jianxin Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-01-30       Impact factor: 4.733

Review 2.  Extracellular Hsp90 (eHsp90) as the actual target in clinical trials: intentionally or unintentionally.

Authors:  Wei Li; Fred Tsen; Divya Sahu; Ayesha Bhatia; Mei Chen; Gabriele Multhoff; David T Woodley
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

Review 3.  Secreted heat shock protein-90 (Hsp90) in wound healing and cancer.

Authors:  Wei Li; Divya Sahu; Fred Tsen
Journal:  Biochim Biophys Acta       Date:  2011-09-25

Review 4.  Heat shock proteins and cancer: intracellular chaperones or extracellular signalling ligands?

Authors:  Stuart K Calderwood
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

5.  Extracellular Hsp90 mediates an NF-κB dependent inflammatory stromal program: implications for the prostate tumor microenvironment.

Authors:  J E Bohonowych; M W Hance; K D Nolan; M Defee; C H Parsons; J S Isaacs
Journal:  Prostate       Date:  2013-12-16       Impact factor: 4.104

6.  Cell surface heparan sulfate proteoglycans are involved in the extracellular Hsp90-stimulated migration and invasion of cancer cells.

Authors:  Anastasiya V Snigireva; Veronika V Vrublevskaya; Yuri Y Skarga; Oleg S Morenkov
Journal:  Cell Stress Chaperones       Date:  2019-01-18       Impact factor: 3.667

7.  Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Matrix Proteolysis.

Authors:  Alexander J Baker-Williams; Fiza Hashmi; Marek A Budzyński; Mark R Woodford; Stephanie Gleicher; Samu V Himanen; Alan M Makedon; Derek Friedman; Stephanie Cortes; Sara Namek; William G Stetler-Stevenson; Gennady Bratslavsky; Alaji Bah; Mehdi Mollapour; Lea Sistonen; Dimitra Bourboulia
Journal:  Cell Rep       Date:  2019-08-13       Impact factor: 9.423

8.  Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer.

Authors:  Michael W Hance; Krystal Dole; Udhayakumar Gopal; Jessica E Bohonowych; Agnieszka Jezierska-Drutel; Carola A Neumann; Haibo Liu; Isla P Garraway; Jennifer S Isaacs
Journal:  J Biol Chem       Date:  2012-09-18       Impact factor: 5.157

Review 9.  Moonlighting proteins in cancer.

Authors:  Kyung-Won Min; Seong-Ho Lee; Seung Joon Baek
Journal:  Cancer Lett       Date:  2015-10-20       Impact factor: 8.679

10.  Extracellular heat shock protein (Hsp)70 and Hsp90α assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion.

Authors:  Jessica D Sims; Jessica McCready; Daniel G Jay
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.